| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
692,978 |
38,492 |
$16.22M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
35,795 |
25,381 |
$4.11M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
53,353 |
35,516 |
$3.48M |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
7,063 |
7,022 |
$1.03M |
| H0025 |
Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior) |
7,345 |
6,857 |
$626K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
3,968 |
3,190 |
$566K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
4,770 |
2,695 |
$289K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,753 |
2,129 |
$283K |
| H0038 |
Self-help/peer services, per 15 minutes |
10,550 |
7,774 |
$210K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
1,046 |
968 |
$188K |
| 99215 |
Prolong outpt/office vis |
969 |
866 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,049 |
915 |
$133K |
| 82075 |
|
3,353 |
451 |
$123K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,579 |
1,307 |
$89K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
567 |
563 |
$86K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
283 |
279 |
$63K |
| H2000 |
Comprehensive multidisciplinary evaluation |
81 |
80 |
$44K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,499 |
1,156 |
$39K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,167 |
1,029 |
$30K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
177 |
177 |
$29K |
| 90791 |
Psychiatric diagnostic evaluation |
205 |
192 |
$23K |
| H0001 |
Alcohol and/or drug assessment |
517 |
511 |
$22K |
| 86580 |
|
2,533 |
2,441 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
453 |
399 |
$18K |
| 80305 |
|
1,359 |
1,285 |
$16K |
| Q3014 |
Telehealth originating site facility fee |
419 |
419 |
$14K |
| H0031 |
Mental health assessment, by non-physician |
78 |
78 |
$13K |
| 90832 |
Psychotherapy, 30 minutes with patient |
265 |
256 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
53 |
$10K |
| 90834 |
Psychotherapy, 45 minutes with patient |
130 |
127 |
$10K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
99 |
93 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
1,399 |
1,104 |
$7K |
| 99406 |
|
485 |
393 |
$6K |
| 81025 |
|
700 |
672 |
$6K |
| 93000 |
|
287 |
276 |
$5K |
| 96160 |
|
530 |
527 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
17 |
$2K |